Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage UVV Q1 2026 Earnings EPS Misses Estimates Sharply on Cost Headwinds CEVA Q1 2026 Earnings EPS Surprises to the Upside Stock Gains Ground Mesa Royalty Trust MTR Q4 2025 Earnings Modest EPS as Royalty Income Continues to Reflect Stable Production SCHL Q1 2026 Earnings NarrowerThanExpected Loss Highlights Resilient Demand BHVN Q1 2026 Earnings EPS Miss Amid Continued RD Investment ADMA Biologics Q1 2026 Earnings EPS Misses Estimates Amid Stock Downdraft GATX Q1 2026 Earnings EPS Beats Estimates Despite Stock Pullback Nasdaq Inc NDAQ Q1 2026 Earnings Modest EPS Beat Amid Market Volatility BBDC Q1 2026 Earnings EPS Falls Short as Stock Rises VPG Q1 2026 Earnings EPS Surprises Positively Amid Quiet Revenue Report Stock Gains Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs